Borgegård, Tomas <br/><br/>
Alzheimer's disease: presenilin 2-sparing γ-secretase inhibition is a tolerable Aβ peptide-lowering strategy.  [electronic resource] 

 -  The Journal of neuroscience : the official journal of the Society for Neuroscience  Nov 2012 
 - 17297-305 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1529-2401 
<br/><br/><label>Standard No.: </label>10.1523/JNEUROSCI.1451-12.2012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--drug therapy<br/>Amyloid Precursor Protein Secretases--antagonists & inhibitors<br/>Amyloid beta-Peptides--metabolism<br/>Animals<br/>Brain--drug effects<br/>Mice<br/>Presenilin-2--genetics<br/>Receptors, Notch--genetics<br/>Signal Transduction--drug effects<br/>Sulfonamides--pharmacology